Hanson & Doremus Investment Management
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1393944
BURLINGTON, VT
Position in REGN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$9,976
-$2,386 QoQ
Shares Held
16
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,221
of 1,322 holders
Holding Since
Mar 2021
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Hanson & Doremus Investment Management holds $275,229 across 2 Biotechnology names. REGN ranks #2 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
534 | $265,253 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
16 | $9,976 |
All Filings in REGN
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,976 | 16 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $12,362 | 16 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $12,349 | 16 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $8,996 | 16 | Shares | Sole | 2025-10-15 | |
| 2024-06-30 | $31,530 | 30 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $28,874 | 30 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $26,348 | 30 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $24,688 | 30 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $21,556 | 30 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $24,650 | 30 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $21,644 | 30 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $20,666 | 30 | Shares | Sole | 2022-10-20 | |
| 2021-12-31 | $631 | 1 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $605 | 1 | Shares | Sole | 2021-10-21 | |
| 2021-03-31 | $473 | 1 | Shares | Sole | 2021-05-03 | |
| No filing history on record for this holder in this stock. | ||||||